The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound annual growth rate (CAGR) of 17.08% during the forecast period 2021-2031.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global electronic connector market is projected to reach $123.90 billion by 2032 from $78.98 billion in 2022, growing at a CAGR of 4.66% during the forecast period 2023-2032.
Get Deailted Insights: https://bisresearch.com/requestsample?id=1573&type=download
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global dental radiography market is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.
The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032.
Precision cardiology industry to be one of the most rapidly evolving and dynamic markets and is predicted to grow at a CAGR of 12.90% over the forecast period of 2021-2031.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032, growing at a CAGR of 13.12% during the forecast period 2022-2032.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global electronic connector market is projected to reach $123.90 billion by 2032 from $78.98 billion in 2022, growing at a CAGR of 4.66% during the forecast period 2023-2032.
Get Deailted Insights: https://bisresearch.com/requestsample?id=1573&type=download
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global dental radiography market is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.
The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032.
Precision cardiology industry to be one of the most rapidly evolving and dynamic markets and is predicted to grow at a CAGR of 12.90% over the forecast period of 2021-2031.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The somatic genetic testing market is expected to grow at a CAGR of 9.30% during the forecast period from 2020 to 2030. The market is projected to reach $16.79 billion by the end of 2030.
The global NGS informatics market is projected to reach $6,715.0 million by 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.
Energy Management System Market is expected to increase at a CAGR of 23.37 percent from 2020 to 2025, from $10.55 billion in 2020 to $30.15 billion in 2025. The increasing demand for energy conservation and environmental safety is likely to fuel the growth of the energy management system market.
Visit: https://bisresearch.com/industry-report/energy-management-system-market.html
Energy Management System Market: Increasing Demand for Energy Conservation an...AmanpreetSingh409
The energy management system has garnered adoption in commercial sectors across various business organizations. The use of energy management systems has helped the residential consumers to analyze a set of data collected from sensors planted at the site.
Read Report Preview: https://bisresearch.com/industry-report/energy-management-system-market.html
DNA Methylation Market _ Industry Analysis & Report BIS Research Inc.
The current DNA methylation market is mainly dominated by several diagnostic majors, such as Exact Sciences Corporation, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc., which offer a wide variety of diagnostics and research-based products for detection of DNA methylation in genomes.
TOC - Global Extensive Stage Small Cell Lung Cancer Market.pdfBIS Research Inc.
Extensive stage small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage small cell lung cancer has been extremely challenging owing to poor survival rate of the patients.
The prevalence of extensive stage small lung cancer is estimated to increase in five of the seven major markets included in the study.
High-performance plastic additives market is projected to reach $2,839.3 million by 2031. High-performance plastic additives industry is in the growth phase and is expected to benefit from the growing implementation of high-performance plastics.
Read Report Overview: https://bisresearch.com/industry-report/high-performance-plastic-additives-market.html
U.S. Hereditary Genetic Testing Market Analysis and Forecast, 2022-2032BIS Research Inc.
The U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is expected to grow with a CAGR of 13.09% and reach $29.28 billion by 2032.
Global advance rocket and missile propulsion system marketMohitDeeptech
Advanced Rocket and Missile Propulsion Systems Market is anticipated to grow at a CAGR of 9.65% based on market value during the forecast period 2020-2025. Advanced rocket and missile propulsion systems Industry demand to grow due to the growing number of satellite launches.
Visit: https://bisresearch.com/industry-report/advanced-rocket-missile-propulsion-systems-market.html
Toc North America Advanced Rocket Missile Propulsion Systems Market Size Es...Harsh Singla
The purpose of North America Advanced Rocket Missile Propulsion Systems Market analysis is to examine the North America advanced rocket and missile propulsion systems in terms of factors driving the market, trends, technological developments, and competitive benchmarking, among others.
The North American advanced rocket and missile propulsion systems industry is expected to grow at a CAGR of 6.94% during the forecast period, 2020-2025.
View the report of North America Advanced Rocket Missile Propulsion Systems Market made by the highly qualified research team of Bis Research:
https://bisresearch.com/industry-report/north-america-advanced-rocket-missile-propulsion-systems-market.html
Get the free sample of the North America Advanced Rocket Missile Propulsion Systems Industry Report exclusively on Bis Research’s Website:
https://bisresearch.com/requestsample?id=1046&type=download
In-vehicle payments market is projected to reach $25,918.6 million by 2031. In-vehicle payment industry is a payment technology-equipped automotive system.
Read Report Overview: https://bisresearch.com/industry-report/in-vehicle-payments-market.html
Our healthcare experts have found COVID-19 Diagnostic Testing industry to be one of the most rapidly evolving and dynamic markets and the global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
Data Center Cooling Market to grow at a CAGR of 16.99% and reach $44.52 billion by 2027. Data Center Cooling Industry is in a growth phase and seen major development by key players.
Read Report Overview: https://bisresearch.com/industry-report/data-center-cooling-market.html
Get Free Sample: https://bisresearch.com/requestsample?id=1413&type=download
Key Start-Ups in the Global Data Center Cooling MarketBIS Research Inc.
The global data center cooling market is expected to grow in the coming years with increased government initiatives and a reduction in operation costs. This would influence the higher adoption of data center cooling technologies due to their high-efficient mechanism, which saves electricity bill costs.
Request Sample Report at: https://bisresearch.com/requestsample?id=1413&type=download
APAC Fluids and Lubricants Market for Electric Vehicles.pdfMohit BISResearch
APAC fluids and lubricants market for electric vehicles is projected to reach $2,363.8 million by 2031 from $182.8 million in 2022, APAC Fluids and Lubricants Industry for Electric Vehicles growing at a CAGR of 32.89% during the forecast period 2022-2031.
Read Report Overview: https://bisresearch.com/industry-report/apac-fluids-lubricants-market-electric-vehicles.html
2D Materials Market growing at a CAGR of 25.3% during the forecast period 2022-2031. 2D materials report is published by bis research focus on end user, material type, and region.
Read Report Overview: https://bisresearch.com/industry-report/2d-materials-market.html
The Blood and Plasma Components Market size in 2020 was $39.58 billion and is expected to reach $66.47 billion in 2031, growing at a CAGR of 4.90% over the forecast period 2021-2031.
Pharmaceutical Aseptic Transfer Market Analysis and Forecast, 2022-2031BIS Research Inc.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020, and it is expected to reach $18,856.6 million by 2031, registering a CAGR of 29.60% during the forecast period.
Automotive Sensors Market - A Global and Regional AnalysisBIS Research Inc.
The automotive sensors market was estimated at $7.45 Billion in 2020 and is projected to grow at a CAGR of 5.47% during the forecast period from 2021-2030.
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
The somatic genetic testing market is expected to grow at a CAGR of 9.30% during the forecast period from 2020 to 2030. The market is projected to reach $16.79 billion by the end of 2030.
The global NGS informatics market is projected to reach $6,715.0 million by 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.
Energy Management System Market is expected to increase at a CAGR of 23.37 percent from 2020 to 2025, from $10.55 billion in 2020 to $30.15 billion in 2025. The increasing demand for energy conservation and environmental safety is likely to fuel the growth of the energy management system market.
Visit: https://bisresearch.com/industry-report/energy-management-system-market.html
Energy Management System Market: Increasing Demand for Energy Conservation an...AmanpreetSingh409
The energy management system has garnered adoption in commercial sectors across various business organizations. The use of energy management systems has helped the residential consumers to analyze a set of data collected from sensors planted at the site.
Read Report Preview: https://bisresearch.com/industry-report/energy-management-system-market.html
DNA Methylation Market _ Industry Analysis & Report BIS Research Inc.
The current DNA methylation market is mainly dominated by several diagnostic majors, such as Exact Sciences Corporation, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc., which offer a wide variety of diagnostics and research-based products for detection of DNA methylation in genomes.
TOC - Global Extensive Stage Small Cell Lung Cancer Market.pdfBIS Research Inc.
Extensive stage small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage small cell lung cancer has been extremely challenging owing to poor survival rate of the patients.
The prevalence of extensive stage small lung cancer is estimated to increase in five of the seven major markets included in the study.
High-performance plastic additives market is projected to reach $2,839.3 million by 2031. High-performance plastic additives industry is in the growth phase and is expected to benefit from the growing implementation of high-performance plastics.
Read Report Overview: https://bisresearch.com/industry-report/high-performance-plastic-additives-market.html
U.S. Hereditary Genetic Testing Market Analysis and Forecast, 2022-2032BIS Research Inc.
The U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is expected to grow with a CAGR of 13.09% and reach $29.28 billion by 2032.
Global advance rocket and missile propulsion system marketMohitDeeptech
Advanced Rocket and Missile Propulsion Systems Market is anticipated to grow at a CAGR of 9.65% based on market value during the forecast period 2020-2025. Advanced rocket and missile propulsion systems Industry demand to grow due to the growing number of satellite launches.
Visit: https://bisresearch.com/industry-report/advanced-rocket-missile-propulsion-systems-market.html
Toc North America Advanced Rocket Missile Propulsion Systems Market Size Es...Harsh Singla
The purpose of North America Advanced Rocket Missile Propulsion Systems Market analysis is to examine the North America advanced rocket and missile propulsion systems in terms of factors driving the market, trends, technological developments, and competitive benchmarking, among others.
The North American advanced rocket and missile propulsion systems industry is expected to grow at a CAGR of 6.94% during the forecast period, 2020-2025.
View the report of North America Advanced Rocket Missile Propulsion Systems Market made by the highly qualified research team of Bis Research:
https://bisresearch.com/industry-report/north-america-advanced-rocket-missile-propulsion-systems-market.html
Get the free sample of the North America Advanced Rocket Missile Propulsion Systems Industry Report exclusively on Bis Research’s Website:
https://bisresearch.com/requestsample?id=1046&type=download
In-vehicle payments market is projected to reach $25,918.6 million by 2031. In-vehicle payment industry is a payment technology-equipped automotive system.
Read Report Overview: https://bisresearch.com/industry-report/in-vehicle-payments-market.html
Our healthcare experts have found COVID-19 Diagnostic Testing industry to be one of the most rapidly evolving and dynamic markets and the global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
Data Center Cooling Market to grow at a CAGR of 16.99% and reach $44.52 billion by 2027. Data Center Cooling Industry is in a growth phase and seen major development by key players.
Read Report Overview: https://bisresearch.com/industry-report/data-center-cooling-market.html
Get Free Sample: https://bisresearch.com/requestsample?id=1413&type=download
Key Start-Ups in the Global Data Center Cooling MarketBIS Research Inc.
The global data center cooling market is expected to grow in the coming years with increased government initiatives and a reduction in operation costs. This would influence the higher adoption of data center cooling technologies due to their high-efficient mechanism, which saves electricity bill costs.
Request Sample Report at: https://bisresearch.com/requestsample?id=1413&type=download
APAC Fluids and Lubricants Market for Electric Vehicles.pdfMohit BISResearch
APAC fluids and lubricants market for electric vehicles is projected to reach $2,363.8 million by 2031 from $182.8 million in 2022, APAC Fluids and Lubricants Industry for Electric Vehicles growing at a CAGR of 32.89% during the forecast period 2022-2031.
Read Report Overview: https://bisresearch.com/industry-report/apac-fluids-lubricants-market-electric-vehicles.html
2D Materials Market growing at a CAGR of 25.3% during the forecast period 2022-2031. 2D materials report is published by bis research focus on end user, material type, and region.
Read Report Overview: https://bisresearch.com/industry-report/2d-materials-market.html
The Blood and Plasma Components Market size in 2020 was $39.58 billion and is expected to reach $66.47 billion in 2031, growing at a CAGR of 4.90% over the forecast period 2021-2031.
Pharmaceutical Aseptic Transfer Market Analysis and Forecast, 2022-2031BIS Research Inc.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020, and it is expected to reach $18,856.6 million by 2031, registering a CAGR of 29.60% during the forecast period.
Automotive Sensors Market - A Global and Regional AnalysisBIS Research Inc.
The automotive sensors market was estimated at $7.45 Billion in 2020 and is projected to grow at a CAGR of 5.47% during the forecast period from 2021-2030.
Similar to Single Cell RNA Sequencing Market.pdf (20)
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
Cybersecurity in Automotive Connected Vehicles and Growing Security Vulnerabi...BIS Research Inc.
• Agenda:
o To evaluate various security vulnerabilities in connected vehicles.
o To analyze the initiatives taken and regulations implemented to address security vulnerabilities.
o To analyze the various types of cybersecurity solutions being developed or offered for the security of connected vehicles.
o To evaluate the major players in the ecosystem.
Report Preview is available at: https://bisresearch.com/industry-report/global-automotive-cybersecurity-market.html
BIS Research conducted a webinar on Carbon Neutral Data Center PracticesBIS Research Inc.
Agenda:
To evaluate various emerging trends in Data center industry.
To analyze the initiatives taken and regulations implemented to increase sustainable practices.
To analyze the various types of technologies currently deployed.
To evaluate the major players in the ecosystem.
Speaker Profiles:
Name: JD Enright, Sr.
Designation: Chief Operating Officer
Company: TMGcore Inc.
Experienced and dedicated business professional with 29 years working with DOD, Multinational Private and Public sector organizations. Primary focus on developing and executing Strategic Step-Up Growth initiatives in Emerging Markets, and Technologies. Specialized leadership in developing improved business operations to include Financial and Operational efficiencies. Implementation of next generation HPC Platforms, Global Blockchain Development Strategies, Biotechnology, Viral Cell and Gene Therapies and Market Intelligence Assimilation for public applications.
Webinar by BIS Research on Precision Oncology BiomarkersBIS Research Inc.
Precision oncology biomarkers are essential tools for tailoring cancer treatment to individual patients, as they provide insights into tumor biology and guide the selection of targeted therapies.
BIS conducted a deep intelligence webinar on the state-of-the-art technologies and emerging strategies used through the precision oncology biomarkers.
Direct-to-Customer Wellness | A Webinar on the Growing Need for Personalized ...BIS Research Inc.
Direct-to-consumer (DTC) wellness testing industry witnessed a strong emphasis on consumer health and wellness, instigating industry stakeholders to discover new revenue streams.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging trends in the healthcare sector, among several other industry verticals. In the bid to do the same, BIS is conducting a deep intelligence webinar on the increasing focus of DTC wellness programs in the healthcare sector.
Read Related Reports Overview at:
https://bisresearch.com/industry-report/global-direct-to-consumer-genetic-testing-market.html
https://bisresearch.com/industry-report/us-dtc-wellness-testing-market.html
Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Bat...BIS Research Inc.
The efficiency of the battery system in any electric vehicle (EV) determines its cost and vehicle performance. Challenges, such as range anxiety and charging time, have been a hindrance to increasing EV sales.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging technologies in the mobility sector, among several other industry verticals.
In the bid to do the same, BIS is conducting a deep intelligence webinar on the current paradigm shift happening for battery technologies in electric vehicles.
Here are all the details:
Webinar Topic: Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Batteries
Webinar on AI in Medical Diagnosis with Emerging TechnologiesBIS Research Inc.
Artificial Intelligence (AI) is a rapidly growing field that has the potential to revolutionize the way medical diagnosis is performed. AI systems use advanced algorithms to analyze large amounts of data, such as medical images, patient histories, and lab results, to identify patterns and make predictions about patient outcomes.
In medical diagnosis, AI can be used in a variety of ways, including medical imaging, disease diagnosis, personalized treatment planning, and early disease detection. By leveraging the power of AI, healthcare providers can make faster and more accurate diagnoses, resulting in better patient outcomes.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Policy implications related to AI and digital transformation in healthcare.
• Initiatives taken and regulations implemented to address cybersecurity concerns.
• Major factors driving and hindering the growth of AI in medical devices diagnosis.
• Major players in the ecosystem
AI-Enabled Imaging Solutions Market - A Global Market Report by BIS ResearchBIS Research Inc.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. you can get more info to visit this link..
https://bisresearch.com/industry-report/global-ai-enabled-medical-imaging-solutions-market.html
The global demand for achieving the net zero emission target by 2050 has pushed governments all over to adapt and adopt advanced carbon removal technologies to go carbon negative.
It is, indeed, an important topic of discussion, because a carbon free environment is the need of the hour to save our planet. And, therefore, BIS Research is glad to announce its upcoming webinar on this particular subject.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Primary sources of carbon emissions and associated environmental issues
• Carbon dioxide removal – key technology and adoption scenario
• Carbon dioxide removal (CDR): trends and key market developments
• Carbon dioxide removal as a credible solution
• Conclusion and future outlook
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentBIS Research Inc.
Agenda of the Webinar:
Cell and Gene Therapy Biomanufacturing Market: Trends and Key Developments
Awaited Technologies in the Cell and Gene Therapy Development
Regulatory Scenario – GMP/cGMP Guidelines
Biomanufacturing 4.0 - Adoption Scenario
Conclusion and Future Outlook
Sub-Orbital Testing Services Market Future Growth and Business Opportunities ...BIS Research Inc.
Sub-orbital platforms are increasing access to the near space-like environment for end users such as government agencies, research institutions, and commercial players.
The competitive landscape of the sub-orbital testing services market consists of several organic and inorganic strategies followed by the key players to increase their market share.
The space industry is continuously innovating and developing advanced technologies with the objective of enhancing space capabilities. The industry is gearing up to develop vehicles that entail a major feature, i.e., reusability.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
TOC - Global Military Robotic and Autonomous Systems (RAS) Market.pdfBIS Research Inc.
The robotic and autonomous system (RAS) is a multidisciplinary scientific and technological domain for implementing complex systems with cognitive capabilities.
RAS in military is being rigorously introduced and used in combat training. This has boosted the capabilities of armed units and subunits. The advent of artificial intelligence (AI) and its integration with military RAS has the potential to change future warfare.
Growing demand to increase warfighter lethality and remove soldiers from dangerous situations is propelling the global military RAS market.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
UAV Propulsion System Market Analysis, Statistics, Regional, and Forecast to ...BIS Research Inc.
UAV propulsion system manufacturers have also been inclined to counter the environment and other government regulations by developing sustainable propulsion, i.e., steps toward fossil-free aviation fuels and ion propulsion are a few of such significant innovations.
UAVs can be powered by a variety of different types of engines, including piston engines, turbine engines, Wankel engines, and electric and solar-powered engines.
The global UAV propulsion system market has witnessed a high growth rate in the last five to six years owing to its widespread applications across various industries, which were further bolstered by the COVID-19 pandemic.
Publication of BIS Research on UAV Propulsion System market has some great insights for UAV Propulsion Systems. Get free sample here: https://bisresearch.com/requestsample?id=1443&type=download
Fleet Management Market Trends, Key Players, Industry Analysis and Forecast 2...BIS Research Inc.
A fleet management system, which includes hardware, software and service, has the ability to make decisions for fleet managers and fleet businesses easily.
The ongoing research and development activities in this market are experiencing product launches of fleet management system for fleet owners, fleet managers, or businesses that utilize fleet management on a daily basis.
BIS Research has a new publication on Fleet Management, view free sample here : https://bisresearch.com/requestsample?id=1444&type=download
Agenda:
The main agenda of this webinar is to understand and explore the following:
• LoRaWAN adoption in agricultural applications as well as understanding the trends and key market developments.
• The significance of LoRaWAN in the field of IoT
• A comparative analysis between LoRaWAN and other IoT networks in terms of technology and capabilities.
• The impact of LoRaWAN on the operations of the agriculture industry and common use cases.
• The impact of the implementation of LoRaWAN technology on stakeholders in the agriculture ecosystem.
• The potential challenges that LoRaWAN might face in the future.
• The competitiveness of the market for LoRaWAN technology.
Augmented Reality in Agriculture Analysis and Statistics from 2022-2027BIS Research Inc.
AR depicts superimposing visual, audio, or other sensory data onto the physical world to improve one's experience. It is one of the most popular technological trends in today’s times. AR images can be displayed on a variety of devices, including eyeglasses and goggles, headsets, and heads-up displays such as helmet visors. As more smartphones, tablets, and other handheld devices that support AR are becoming available globally, the most popular way to use AR is on these devices in a variety of apps and games.
Although AR is used to visually communicate information, it is the integration of AR with other technologies that make it possible to adapt to precision farming and visual-based operations. Hence, farmers can utilize AR in combination with other technologies such as artificial intelligence (AI), big data, and the Internet of Things (IoT) to manage the rising food demand.
Get Augmented Reality in Agriculture report overview at: https://bisresearch.com/industry-report/ar-agriculture-market.html
Smart Harvest Market Generated Opportunities, Future Scope 2022-2027BIS Research Inc.
The growth in the global smart harvest market is expected to be driven by increasing smart farming practices among farmers, labor shortage, and growing government support for promoting the use of smart tech in the agriculture industry. Supported by government policies and technological developments, farmers and growers across the globe are expected to increase the implementation of smart harvest technologies. Moreover, the smart harvest market is witnessing several upcoming trends and opportunities, further propelling growth in the industry.
Get the PDF document on the technical aspects of Smart Harvest Market at: https://bisresearch.com/requestsample?id=1386&type=download
Precision Pest Management Market Leading Players, Development and Demand Fore...BIS Research Inc.
While farmers are losing crops due to pests, they have pressure to increase food production to feed the growing world population.
Precision pest management (PPM) is very important to avoid destruction caused by pests and to increase productivity. PPM helps to detect pests early with the help of crop monitoring so they can be controlled early to avoid further losses. The availability of advanced technologies and equipment has made agriculture automation more prevalent in developed countries.
To know more about the in-depth insights on precision pest management market, get PDF document: https://bisresearch.com/requestsample?id=1404&type=download
Agriculture Drones and Robots Market Growth Opportunity, Trends, Demand Analy...BIS Research Inc.
Agriculture drones and robots offer multiple benefits over conventional farming equipment, which is another factor driving the demand for these products in the agriculture industry. The adoption of agriculture drones and robots in commercial farms offers huge cost-saving opportunities.
Request for the Sample of the Report at: https://bisresearch.com/requestsample?id=1425&type=download
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
1. 1
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
https://www.shutterstock.com/image-illustration/messenger-rna-mrna-strand-3d-rendering-1907619631
Focus on Product, Workflow, End User and
Application, Supply Chain, and Country-
Wise Analysis
Analysis and Forecast: 2021-2031
February 2022
Global Single Cell
RNA Sequencing
Market -
A Global and
Regional Analysis
Table of Content
3. 3
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Table of Content
Executive Summary..........................................................................17
1. Product Definition......................................................................21
1.1 Inclusions and Exclusions..............................................................................21
2. Research Scope and Methodology.............................................22
2.1 Research Scope...............................................................................................22
2.2 Global Single Cell RNA Sequencing Market: Research Methodology ........23
2.3 Primary Data Sources .....................................................................................24
2.4 Secondary Data Sources ................................................................................25
2.5 Market Estimation Model.................................................................................26
2.6 Key Questions Answered in This Report.......................................................28
3. Markets .....................................................................................29
3.1 Market Overview ..............................................................................................30
3.1.1 Introduction of Single Cell RNA Sequencing............................................30
3.1.2 Current Applications of Single Cell RNA Sequencing .............................31
3.1.3 Comparative Analysis of Single Cell RNA Sequencing Technology
and Conventional RNA Sequencing Technology .....................................31
3.1.4 Single Cell RNA Sequencing Market..........................................................32
3.2 Impact of COVID-19 on Global Single Cell RNA Sequencing Market ..........33
3.3 COVID-19 Affecting Supply Chain of Single Cell RNA Sequencing
Market ...............................................................................................................34
3.4 Interruption in Research and Clinical Development and Commercial
Operation..........................................................................................................35
3.4.1 Research and Clinical Development..........................................................35
3.4.2 Commercial Operation and Access............................................................35
3.5 Navigating Crisis Recovery and Looking to the Future ...............................35
3.6 Legal Requirements and Regulations............................................................36
3.6.1 Legal Requirements and Framework in the U.S. ......................................36
3.6.2 Legal Requirements and Regulations in Europe......................................39
3.6.3 Legal Requirements and Framework in the Asia-Pacific.........................41
4. 4
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
3.6.3.1 China ................................................................................................................. 41
3.6.3.2 Japan................................................................................................................. 41
4. Market Dynamics .......................................................................43
4.1 Market Drivers..................................................................................................43
4.1.1 Rising Applications of Single Cell RNA Sequencing in Cancer
Studies and Treatment................................................................................43
4.1.2 Increasing Awareness and Acceptance of Personalized
Diagnostics on a Global Level ...................................................................46
4.1.3 Decreasing Cost of Sequencing.................................................................47
4.1.4 Increasing Government Funding for Healthcare ......................................48
4.2 Business Challenges.......................................................................................49
4.2.1 Computational Challenges in Data Analysis of ScRNA Sequencing......49
4.2.2 High Capital Requirement...........................................................................49
4.2.3 Lack of Infrastructure and Expertise .........................................................50
4.3 Business Opportunities ..................................................................................50
4.3.1 Expansion into Emerging Markets.............................................................50
4.3.2 Expansion into New Research Application...............................................51
4.3.3 Expansion of the Product Portfolio ...........................................................51
5. Competitive Landscape .............................................................52
5.1 New Offerings ..................................................................................................53
5.2 Mergers and Acquisitions...............................................................................53
5.3 Synergistic Activities ......................................................................................54
5.4 Business Expansion and Other Strategies....................................................55
5.5 Market Share Analysis, By Company.............................................................56
6. Global Single Cell RNA Sequencing Market (by Offering)............57
6.1 Global Single Cell RNA Sequencing Market (by Offerings) ), $ Million,
2020-2031..........................................................................................................58
6.1.1 Consumables...............................................................................................59
6.1.2 Instruments..................................................................................................59
7. Global Single Cell RNA Sequencing Market (by Workflow), $
Million, 2020-2031......................................................................61
5. 5
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
7.1 Single Cell Isolation.........................................................................................63
7.1.1 Laser Capture Microscopy (LCM) ..............................................................63
7.1.2 Flow-Activated Cell Sorting (FACS)...........................................................64
7.1.3 Magnetic-Activated Cell Sorting (MACS)...................................................65
7.1.4 Microfluidics ................................................................................................66
7.2 Single Cell Amplification.................................................................................66
7.3 Library Preparation..........................................................................................67
8. Global Single Cell RNA Sequencing Market (by Application), $
Million, 2020-2031......................................................................69
8.1.1 Oncology......................................................................................................70
8.1.2 Immunology .................................................................................................71
8.1.3 Neurology.....................................................................................................72
8.1.4 Embryology..................................................................................................74
8.1.5 Others...........................................................................................................74
9. Global Single Cell RNA Sequencing (by End User), $Million,
2020 and 2031 ...........................................................................76
9.1 Research Organizations..................................................................................77
9.2 Biopharmaceutical Companies ......................................................................78
9.3 Others ...............................................................................................................79
10. Global Single Cell RNA Sequencing Market (by Region) , $
Million, 2020-2031......................................................................81
10.1 North America..................................................................................................84
10.1.1 U.S. ...............................................................................................................85
10.1.2 Canada .........................................................................................................86
10.2 Europe ..............................................................................................................89
10.2.1 U.K. ...............................................................................................................91
10.2.2 Germany.......................................................................................................91
10.2.3 Italy ...............................................................................................................92
10.2.4 Spain.............................................................................................................93
10.2.5 France...........................................................................................................94
6. 6
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
10.2.6 Rest-of-Europe.............................................................................................95
10.3 Asia-Pacific ......................................................................................................98
10.3.1 Japan............................................................................................................99
10.3.2 China ..........................................................................................................100
10.3.3 India............................................................................................................101
10.3.4 South Korea ...............................................................................................102
10.3.5 Australia.....................................................................................................103
10.3.6 Rest-of-Asia-Pacific...................................................................................104
10.4 Rest-of-the-World ..........................................................................................105
11. Company Profiles.....................................................................107
11.1 Company Profiles ..........................................................................................108
11.2 10x Genomics, Inc. ........................................................................................109
11.2.1 Company Overview ...................................................................................109
11.2.2 Role of 10x Genomics, Inc. in Global Single Cell RNA Sequencing
Market.........................................................................................................109
11.2.3 Key Competitors of the Company............................................................110
11.2.4 Financials...................................................................................................111
11.2.5 Key Insights About Financial Health of the Company ...........................113
11.2.6 SWOT Analysis..........................................................................................114
11.3 BGI Group.......................................................................................................115
11.3.1 Company Overview ...................................................................................115
11.3.2 Role of BGI Group in the Global Single Cell RNA Sequencing Market
....................................................................................................................115
11.3.3 Key Competitors of the Company............................................................116
11.3.4 SWOT Analysis..........................................................................................116
11.4 Bio-Rad Laboratories, Inc. ............................................................................117
11.4.2 Company Overview ...................................................................................117
11.4.3 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell RNA
Sequencing Market....................................................................................117
11.4.4 Key Competitors of the Company............................................................118
7. 7
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
11.4.5 Financials...................................................................................................119
11.4.6 Key Insights About Financial Health of the Company ...........................121
11.4.7 SWOT Analysis..........................................................................................122
11.5 Becton, Dickinson and Company (BD) ........................................................123
11.5.1 Company Overview ...................................................................................123
11.5.2 Role of Becton, Dickinson and Company (BD) in the Global Single
Cell RNA Sequencing Market ...................................................................123
11.5.3 Key Competitors of the Company............................................................124
11.5.4 Financials...................................................................................................125
11.5.5 Key Insights About Financial Health of the Company ...........................127
11.5.6 SWOT Analysis..........................................................................................128
11.6 Fluidigm Corporation ....................................................................................129
11.6.1 Company Overview ...................................................................................129
11.6.2 Role of Fluidigm Corporation in the Global Single Cell RNA
Sequencing Market....................................................................................129
11.6.3 Key Competitors of the Company............................................................130
11.6.4 Key Insights About Financial Health of the Company ...........................130
11.6.5 SWOT Analysis..........................................................................................133
11.7 MedGenome ...................................................................................................134
11.7.1 Company Overview ...................................................................................134
11.7.2 Role of MedGenome in the Global Single Cell RNA Sequencing
Market.........................................................................................................134
11.7.3 Key Competitors of the Company............................................................135
11.7.4 SWOT Analysis..........................................................................................136
11.8 NanoString Technologies, Inc. .....................................................................137
11.8.1 Company Overview ...................................................................................137
11.8.2 Role of NanoString Technologies, Inc. in the Global Single Cell RNA
Sequencing Market....................................................................................137
11.8.3 Key Competitors of the Company............................................................138
11.8.4 Key Insights About Financial Health of the Company ...........................138
11.8.5 SWOT Analysis..........................................................................................141
8. 8
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
11.9 Pacific Biosciences of California, Inc. .........................................................142
11.9.1 Company Overview ...................................................................................142
11.9.2 Role of Pacific Biosciences of California, Inc. in the Global Single
Cell RNA Sequencing Market ...................................................................142
11.9.3 Key Competitors of the Company............................................................143
11.9.4 Financials...................................................................................................143
11.9.5 Key Insights About Financial Health of the Company ...........................145
11.9.6 SWOT Analysis..........................................................................................146
11.10 QIAGEN N.V....................................................................................................147
11.10.1 Company Overview.............................................................................147
11.10.2 Role of QIAGEN N.V. in the Global Single Cell RNA Sequencing
Market.........................................................................................................147
11.10.3 Key Competitors of the Company .....................................................148
11.10.4 Financials ............................................................................................148
11.10.5 Key Insights About Financial Health of the Company .....................151
11.10.6 SWOT Analysis....................................................................................152
11.11 PerkinElmer Inc..............................................................................................153
11.11.1 Company Overview.............................................................................153
11.11.2 Role of PerkinElmer Inc. in the Global Single Cell RNA
Sequencing Market....................................................................................153
11.11.3 Key Competitors of the Company .....................................................154
11.11.4 Financials ............................................................................................155
11.11.5 Key Insights About Financial Health of the Company .....................157
11.11.6 SWOT Analysis....................................................................................158
11.12 Takara Bio, Inc. ..............................................................................................159
11.12.1 Company Overview.............................................................................159
11.12.2 Role of Takara Bio, Inc. in the Global Single Cell RNA
Sequencing Market....................................................................................159
11.12.3 Key Competitors of the Company .....................................................159
11.12.4 Key Insights about Financial Health of Company............................160
11.12.5 SWOT Analysis....................................................................................162
9. 9
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
11.13 Thermo Fisher Scientific Inc.........................................................................163
11.13.1 Company Overview.............................................................................163
11.13.2 Role of Thermo Fisher Scientific Inc. in the Global Single Cell
RNA Sequencing Market...........................................................................163
11.13.3 Key Competitors of the Company .....................................................164
11.13.4 Financials ............................................................................................164
11.13.5 Key Insights About Financial Health of the Company .....................166
11.13.6 SWOT Analysis....................................................................................167
Emerging Companies .....................................................................168
11.14 Biomage Ltd...................................................................................................168
11.15 Nucleome Informatics Pvt Ltd. .....................................................................168
11.16 Scailyte ...........................................................................................................169
11.17 Analytical Biosciences Limited. ...................................................................169
10. 10
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
List of Figures
Figure 1: Trends in Single Cell Studies, November 2019-May 2020
Figure 2: Global Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 3: Impact Analysis of Market Drivers and Market Challenges
Figure 4: Share of Key Market Strategies and Developments, January 2017- January 2022
Figure 5: Global Single Cell RNA Sequencing Market (by Region), 2020 and 2031
Figure 6: Global Single Cell RNA Sequencing Market Segmentation
Figure 7: Global Single Cell RNA Sequencing Market Research Methodology
Figure 8: Primary Research
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Development History of Single Cell Sequencing
Figure 11: Global Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 12: Positive and Negative Impact of COVID-19 on Single Cell RNA Sequencing Market
Figure 13: Measure to Navigate Crisis Recovery
Figure 14: Global Single Cell RNA Sequencing Market Dynamics
Figure 15: Rising Number of New Cancer Cases (Comparative Analysis of the Cases in 2018 and 2020)
Figure 16: Applications of Single Cell RNA Sequencing in Analysis of Tumour Heterogeneity
Figure 17: Issues Addressed by Single Cell RNA Sequencing in Oncogenomics
Figure 18: Increasing Government Spending for Healthcare, 2017
Figure 19: Share of Key Market Strategies and Developments, January 2017- January 2022
Figure 20: Share of New Offerings (by Company), January 2017-January 2022
Figure 21: Share of Mergers and Acquisitions (by Company), January 2017-January 2022
Figure 22: Share of Synergistic Activities (by Company), January 2017-January 2022
Figure 23: Share of Business Expansion and Other Strategies (by Company), January 2017-January
2022
Figure 24: Market Share Analysis of Global Single Cell RNA Sequencing Market (by Company), 2020
and 2021
Figure 25: Global Single Cell RNA Sequencing (by Offerings), $Million, 2020 and 2031
Figure 26: Global Single Cell RNA Sequencing Consumables Market, $Million, 2020-2031
Figure 27: Global Single Cell RNA Sequencing Instruments Market, $Million, 2020-2031
Figure 28: Global Single Cell RNA Sequencing (by Workflow), $Million, 2020 and 2031
Figure 29: Global Single Cell RNA Sequencing Market (Single Cell Isolation), $ Million, 2020-2031
11. 11
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 30: Global Single Cell RNA Sequencing Laser Capture Microscopy Market, $Million, 2020-2031
Figure 31: Global Single Cell RNA Sequencing Flow-Activated Cell Sorting Market, $ Million, 2020-2031
Figure 32: Global Single Cell RNA Sequencing Magnetic-Activated Cell Sorting Market, $Million, 2020-
2031
Figure 33: Global Single Cell RNA Sequencing Microfluidics Market, $Million, 2020-2031
Figure 34: Global Single Cell RNA Sequencing Market (Single Cell Amplification), $Million, 2020-2031
Figure 35: Global Single Cell RNA Sequencing Market (Library Preparation), $Million, 2020-2031
Figure 36: Global Single Cell RNA Sequencing (by Application), $Million, 2020 and 2031
Figure 37: Global Single Cell RNA Sequencing Market (Oncology), $Million, 2020-2031
Figure 38: Global Single Cell RNA Sequencing Market (Immunology), $Million, 2020-2031
Figure 39: Global Single Cell RNA Sequencing Market (Neurology), $Million, 2020-2031
Figure 40: Global Single Cell RNA Sequencing Market (Embryology), $Million, 2020-2031
Figure 41: Global Single Cell RNA Sequencing Market (Others), $Million, 2020-2031
Figure 42: Global Single Cell RNA Sequencing (by End-User Type), $Million, 2020 and 2031
Figure 43: Global Single Cell RNA Sequencing Market (Research Organizations), $Million, 2020-2031
Figure 44: Global Single Cell RNA Sequencing Market (Biopharmaceutical Companies), $Million, 2020-
2031
Figure 45: Global Single Cell RNA Sequencing Market (Others), $Million, 2020-2031
Figure 46: Global Single Cell RNA Sequencing Market (by Region), $Million, 2020 and 2031
Figure 47: North America Global Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 48: North America: Market Dynamics
Figure 49: U.S. Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 50: Canada Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 51: Europe Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 52: Europe: Market Dynamics
Figure 53: U.K. Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 54: Germany Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 55: Italy Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 56: Spain Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 57: France Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 58: Rest-of-Europe Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 59: Asia-Pacific Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 60: Asia-Pacific: Market Dynamics
12. 12
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 61: Japan Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 62: China Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 63: India Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 64: South Korea Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 65: Australia Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 66: Rest-of-Asia-Pacific Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 67: Rest-of-the-World Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 68: Share of Key Companies Profiled
Figure 69: 10x Genomics, Inc.: Product Portfolio
Figure 70: 10x Genomics, Inc.: Overall Financials, $Million, 2017-2019
Figure 71: 10x Genomics, Inc.: Revenue (by Business Segment), $Million, 2017-2019
Figure 72: 10x Genomics, Inc.: Revenue (by Region), $Million, 2017-2019
Figure 73: : 10x Genomics, Inc.: R&D Expenditure, $Million, 2017-2019
Figure 74: 10x Genomics, Inc.: SWOT Analysis
Figure 75: BGI Group: Product Portfolio
Figure 76: BGI Group: SWOT Analysis
Figure 77: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 78: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020
Figure 79: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 80: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 81: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 82: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 83: Becton, Dickinson and Company (BD): Product Portfolio
Figure 84: Becton, Dickinson and Company (BD): Overall Financials, $Million, 2018-2020
Figure 85: Becton, Dickinson and Company (BD): Revenue (by Segment), $Million, 2018-2020
Figure 86: Becton, Dickinson and Company (BD): Revenue (by Region), $Million, 2018-2020
Figure 87: Becton, Dickinson and Company (BD): R&D Expenditure, $Million, 2018-2020
Figure 88: Becton, Dickinson and Company: SWOT Analysis
Figure 89: Fluidigm Corporation: Overall Financials, $Million, 2016-2018
Figure 90: Fluidigm Corporation: Revenue (by Business Segment), $Million, 2016-2018
Figure 91: Fluidigm Corporation: Revenue (by Region), $Million, 2016-2018
Figure 92: Fluidigm Corporation: R&D Expenditure, $Million, 2016-2018
Figure 93: Fluidigm Corporation: SWOT Analysis
13. 13
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 94: MedGenome: Product Portfolio
Figure 95: MedGenome: SWOT Analysis
Figure 96: NanoString Technologies, Inc.: Overall Financials, $Million, 2016-2018
Figure 97: NanoString Technologies, Inc.: Revenue (by Business Segment), $Million, 2016-2018
Figure 98: NanoString Technologies, Inc.: Revenue (by Region), $Million, 2016-2018
Figure 99: NanoString Technologies, Inc.: R&D Expenditure, $Million, 2016-2018
Figure 100: NanoString Technologies, Inc.: R&D Expenditure (by Functional Area), $Million, 2016-2018
Figure 101: NanoString Technologies, Inc.: SWOT Analysis
Figure 102: Pacific Biosciences of California, Inc.: Product Portfolio
Figure 103: Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020
Figure 104: Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 105: Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 106: Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 107: Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 108: QIAGEN N.V.: Product Portfolio
Figure 109: QIAGEN N.V.: Overall Financials, $Million, 2018-2020
Figure 110: QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020
Figure 111: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020
Figure 112: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020
Figure 113: QIAGEN N.V.: SWOT Analysis
Figure 114: PerkinElmer Inc.: Product Portfolio
Figure 115: PerkinElmer Inc.: Overall Financials, $Million, 2018-2020
Figure 116: PerkinElmer Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 117: PerkinElmer Inc.: Revenue (by Region), $Million, 2018-2020
Figure 118: PerkinElmer Inc.: R&D Expenditure, $Million, 2018-2020
Figure 119: PerkinElmer Inc.: SWOT Analysis
Figure 120: Takara Bio Inc.: Overall Financials, $Million, 2015-2017
Figure 121: Takara Bio, Inc.: Revenue (by Business Segment), $Million, 2015-2017
Figure 122: Takara Bio, Inc.: Revenue (by Region), $Million, 2017
Figure 123: Takara Bio, Inc.: R&D Expenditure, $Million, 2015-2017
Figure 124: Takara Bio Inc.: SWOT Analysis
Figure 125: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 126: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
14. 14
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 127: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 128: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018–2020
Figure 129: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 130: Thermo Fisher Scientific Inc.: SWOT Analysis
15. 15
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
List of Tables
Table 1: Difference between Single Cell RNA Sequencing and RNA Sequencing
Table 2: Classification of Directive Groups IVDs
Table 3: Declining Cost of Genome
16. 16
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions
worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other
innovative solutions.
Know More Know More
Know More
Know More
17. 17
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published, or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties and contingencies
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135
18. 18
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
S
I
N
G
L
E
C
E
L
L
R
N
A
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com